Keyphrases
Prognostic Factors
81%
Chemotherapy
51%
Radiation Therapy
45%
Medical Center
43%
Kaposi Sarcoma
40%
Disease-free Survival
39%
Adjuvant Chemotherapy
38%
Rabin
38%
Radiotherapy
37%
Israel
33%
Multivariate Analysis
32%
Nodal Status
31%
Breast Cancer Patients
31%
Tumor
27%
Locally Advanced Breast Cancer
27%
Estrogen Receptor
27%
Carcinoma
27%
Malignant Lymphoma
27%
Post-chemotherapy
27%
Non-Hodgkin Lymphoma
27%
Overall Survival
25%
Locoregional
24%
Advanced Laryngeal Cancer
22%
Univariate Analysis
22%
Recurrent Disease
22%
Induction Chemotherapy
22%
Hormone Receptor-positive
22%
Lymphoma
21%
Tumor Marker
20%
Irradiation
20%
Consecutive Patients
19%
Hormonal Therapy
19%
Retrospective Analysis
18%
Breast Carcinoma
18%
Disease-free Interval
18%
Serum Levels
18%
Progesterone Receptor
18%
Complete Response
18%
Response to Treatment
18%
Cisplatin
16%
Clinical Course
16%
Radiochemotherapy
16%
Ashkenazi Jews
16%
Histological Subtypes
15%
High Incidence
15%
5-year Survival
15%
Old Age
15%
Leucovorin
14%
T Stage
14%
Malignant Melanoma
14%
Medicine and Dentistry
Radiation Therapy
100%
Prognostic Factor
81%
Neoplasm
80%
Diseases
63%
Kaposi Sarcoma
40%
Breast Cancer
40%
Laryngeal Cancer
40%
Recurrent Disease
38%
Adjuvant Chemotherapy
33%
Overall Survival
32%
Disease Free Survival
31%
Multivariate Analysis
31%
Locally Advanced Breast Cancer
27%
Tumor Marker
27%
Carcinoma
27%
Survival Rate
25%
Hormone Therapy
23%
Induction Chemotherapy
21%
Non-Hodgkin Lymphoma
20%
Univariate Analysis
19%
Disease Course
18%
Receptor
18%
Breast Carcinoma
16%
Neck
14%
Melanoma
14%
Primary Tumor
14%
Male Breast
13%
Leiomyosarcoma
13%
Nasopharynx
13%
Non Small Cell Lung Cancer
13%
Carcinogenesis
13%
Clinical Guideline
13%
Gastric Lymphoma
13%
Chemoradiotherapy
13%
Vagina Mucosa
13%
Merkel Cell Carcinoma
13%
Estrogen Receptor
13%
Lymphoblastic Lymphoma
13%
Clinical Study
13%
Larynx Carcinoma
13%
Factor Analysis
13%
Cisplatin
13%
Pleura Effusion
13%
Retrospective Study
13%
Skin Cancer
13%
Paraaortic Lymph Node
13%
Cervical Cancer
13%
Systemic Therapy
13%
Ovarian Cancer
13%
Colorectal Carcinoma
13%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
83%
Diseases
65%
Neoplasm
57%
Recurrent Disease
35%
Carcinoma
27%
Breast Cancer
27%
Colorectal Carcinoma
27%
Larynx Cancer
22%
Disease Free Survival
22%
Survival Rate
21%
Folinic Acid
20%
Methotrexate
18%
Primary Tumor
17%
Cisplatin
16%
Melanoma
14%
Kaposi Sarcoma
13%
Chemoradiation Therapy
13%
Non Small Cell Lung Cancer
13%
Ovary Cancer
13%
Hyperthermia
13%
Porphobilinogen Deaminase
13%
Leukoencephalopathy
13%
Larynx Carcinoma
13%
Merkel Cell Carcinoma
13%
Carcinogenesis
13%
Nuclear Estrogen
13%
Polypeptide
13%
Skin Cancer
13%
Liver Metastasis
13%
Progesterone Receptor
13%
Clinical Trial
13%
Granulocyte Macrophage Colony Stimulating Factor
13%
Retrospective Study
13%
Systemic Treatment
13%
Estrogen Receptor
13%
Alpha Interferon
13%
Metastatic Melanoma
13%
Overall Survival
11%
Remission
11%
Disease Exacerbation
10%
Fluorouracil
9%
Nonhodgkin Lymphoma
9%
Progesterone
9%
Receptor
8%
Fluoropyrimidine
6%
Isoniazid
6%
Bone Marrow Toxicity
6%
Neutropenia
6%
Liver Disease
6%
Carcinoembryonic Antigen
5%